Nextcure Inc. (NXTC) Stock Performance
- Closing price (01:21 AM CET, Wednesday 21st): USD 5.44
- Day‑to‑day change: down 9.13 %
- Current supply: 4.6 million shares
- Market capitalisation: USD 28.6 million
- Volume traded in last 24 hours: USD 381.6 k
- Change since last month‑end: up 3.85 %
- 200‑day simple moving average: USD 8.20
- 52‑week high: USD 15.74 (24 Nov 2025)
- 52‑week low: USD 1.55 (26 Jun 2026)
Related Stock Movements (last 24 hours)
| Ticker | Name | 24‑hour change | Current price | Market cap |
|---|---|---|---|---|
| CRVO | Cervomed | +3.12 % | USD 2.29 | USD 33.9 million |
| KOSS | Koss | –2.73 % | USD 3.56 | USD 34.1 million |
| COSM | Cosmos Health | –1.81 % | USD 0.33 | USD 33.3 million |
| BOF | Branchout Food /Or | +1.37 % | USD 2.18 | USD 33.5 million |
| FLNA | Filana Therapeutics | –2.86 % | USD 0.69 | USD 34.0 million |
Company Overview
NextCure, Inc. is a clinical‑stage biopharmaceutical company focused on immunomedicines for cancer and related diseases. The company is headquartered in Beltsville, Maryland, and operates within the health‑care sector. More information is available on the company’s website, www.nextcure.com , and its shares are listed on the Nasdaq stock exchange.
